Literature DB >> 20015272

Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjögren's syndrome but not in the maintenance.

Y Ozaki1, T Ito, Y Son, H Amuro, K Shimamoto, H Sugimoto, Y Katashiba, M Ogata, R Miyamoto, N Murakami, R Amakawa, S Fukuhara.   

Abstract

We have demonstrated previously that, in primary Sjögren's syndrome (SS), immature myeloid dendritic cells (DCs) are decreased in blood and mature myeloid DCs are accumulated in salivary glands, suggesting recruitment of the myeloid DCs from blood to salivary glands. To verify whether this finding is universal in patients of not only primary SS but also secondary SS, in this study we analysed the blood DCs of secondary SS patients. We examined 24 secondary SS and 29 primary SS patients. A direct correlation between the decreased number of myeloid DCs and the duration of Sicca syndrome in primary and secondary SS was observed; namely, the reduction of myeloid DCs in blood was restored spontaneously with duration time of Sicca syndrome. We also examined the immunohistochemical staining of salivary glands of SS patients with monoclonal antibodies against fascin, CD11c and human leucocyte antigen DR (HLA-DR). Fascin(+) or CD11c(+)/HLA-DR(+) mononuclear cells were present in the salivary glands of secondary SS patients, as in primary SS. However, fascin(+) mononuclear cells were barely detected in the salivary glands of a chronic phase of SS patients. We also found a negative correlation between the frequency of blood myeloid DCs and salivary gland-infiltrating DCs in secondary SS patients, as well as primary SS. Our results suggest that the reduction of blood myeloid DCs and preferential trafficking of myeloid DCs into salivary glands is a common event in the early stage of SS. Myeloid DCs may play essential roles in the pathogenesis of Sicca syndrome of SS by initiating T helper cell immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015272      PMCID: PMC2819497          DOI: 10.1111/j.1365-2249.2009.04071.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.

Authors:  E C Kolkowski; P Reth; F Pelusa; J Bosch; R Pujol-Borrell; J Coll; D Jaraquemada
Journal:  J Autoimmun       Date:  1999-08       Impact factor: 7.094

2.  A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells.

Authors:  T Ito; M Inaba; K Inaba; J Toki; S Sogo; T Iguchi; Y Adachi; K Yamaguchi; R Amakawa; J Valladeau; S Saeland; S Fukuhara; S Ikehara
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

Review 3.  The control of T cell responses by dendritic cell subsets.

Authors:  S D Reid; G Penna; L Adorini
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

Review 4.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

5.  The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells.

Authors:  R Ross; X L Ross; J Schwing; T Längin; A B Reske-Kunz
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

6.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

7.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; I Durand; M Cella; A Lanzavecchia; J Banchereau
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

8.  Reciprocal control of T helper cell and dendritic cell differentiation.

Authors:  M C Rissoan; V Soumelis; N Kadowaki; G Grouard; F Briere; R de Waal Malefyt; Y J Liu
Journal:  Science       Date:  1999-02-19       Impact factor: 47.728

9.  Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.

Authors:  R I Fox; H I Kang; D Ando; J Abrams; E Pisa
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

10.  Significance of oral examination in chronic graft-versus-host disease.

Authors:  A Hiroki; S Nakamura; M Shinohara; M Oka
Journal:  J Oral Pathol Med       Date:  1994-05       Impact factor: 4.253

View more
  12 in total

Review 1.  Dendritic cells of the oral mucosa.

Authors:  A-H Hovav
Journal:  Mucosal Immunol       Date:  2013-06-12       Impact factor: 7.313

Review 2.  Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.

Authors:  Hawra Aljanobi; Amarpreet Sabharwal; Bralavan Krishnakumar; Jill M Kramer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-01-24

Review 3.  Innate immunity in Sjögren's syndrome.

Authors:  Jeremy Kiripolsky; Liam G McCabe; Jill M Kramer
Journal:  Clin Immunol       Date:  2017-04-08       Impact factor: 3.969

4.  Bioinformatics analysis identified immune infiltration, risk and drug prediction models of copper-induced death genes involved in salivary glands damage of primary Sjögren's syndrome.

Authors:  Naidan Zhang; Chaixia Ji; Xinyin Peng; Maoju Tang; Xiao Bao; Chengliang Yuan
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 5.  Contributions of Major Cell Populations to Sjögren's Syndrome.

Authors:  Richard Witas; Shivai Gupta; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2020-09-22       Impact factor: 4.241

6.  Distribution of dendritic cells in normal human salivary glands.

Authors:  An Le; Michele Saverin; Arthur R Hand
Journal:  Acta Histochem Cytochem       Date:  2011-07-20       Impact factor: 1.938

7.  MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1.

Authors:  Ana P Lopes; Joel A G van Roon; Sofie L M Blokland; Maojie Wang; Eleni Chouri; Sarita A Y Hartgring; Kim M G van der Wurff-Jacobs; Aike A Kruize; Boudewijn M T Burgering; Marzia Rossato; Timothy R D J Radstake; Maarten R Hillen
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

8.  Interleukin‑12 exacerbates Sjögren's syndrome through induction of myeloid‑derived suppressor cells.

Authors:  Jingjing Qi; Dan Li; Guoping Shi; Xuefang Zhang; Yuchen Pan; Huan Dou; Tingting Wang; Genhong Yao; Yayi Hou
Journal:  Mol Med Rep       Date:  2019-06-06       Impact factor: 2.952

Review 9.  The Involvement of Innate and Adaptive Immunity in the Initiation and Perpetuation of Sjögren's Syndrome.

Authors:  Clara Chivasso; Julie Sarrand; Jason Perret; Christine Delporte; Muhammad Shahnawaz Soyfoo
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

10.  Advances in Pathogenesis of Sjögren's Syndrome.

Authors:  Yao Tian; Hongyi Yang; Na Liu; Yan Li; Jie Chen
Journal:  J Immunol Res       Date:  2021-10-07       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.